Newsroom

DUBLIN--(BUSINESS WIRE)--The "Mastering DHF, DMR & DHR - Essential FDA Documentation for Medical Devices (February 3, 2026)" training has been added to ResearchAndMarkets.com's offering. Medical device manufacturing is not an easy process. If anything goes wrong, the entire batch of products is at stake. Is there any solution to it? DHF, DMR, and DHR are the three Ds of medical device that needs to be managed carefully. Even though these files serve different purposes, it is essential to un...

NEW YORK--(BUSINESS WIRE)--Ninth Wave Introduces Compass, an AI-Driven Onboarding Assistant that Radically Simplifies and Accelerates Open Finance Integration....

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/12/2026 Issue ¦ QNB Finance Ltd- Series 392 USD 25,000,000 FRN due January 2027     ISIN Number ¦ XS2433158677 ISIN Reference ¦ 243315867 Issue Nomin USD ¦ 25000000 Period ¦ 10/20/2025 to 1/20/2026   Payment Date 1/20/2026 Number of Days ¦ 92 Rate ¦ 4.93319   Denomination USD ¦ 200000   ¦ 25000000   ¦       Amount Payable per Denomination ¦ 2521.41   ¦ 315176.03   ¦       Bank of New York     Rate...

LYON, Francia--(BUSINESS WIRE)--Fabentech, empresa biofarmacéutica francesa especializada en medidas médicas en respuesta a amenazas biológicas, anunció hoy que ha recibido la autorización de comercialización para Ricimed®, un tratamiento para la intoxicación por ricina. El comunicado en el idioma original es la versión oficial y autorizada del mismo. Esta traducción es solamente un medio de ayuda y deberá ser comparada con el texto en idioma original, que es la única versión del texto que tend...

LIONE, Francia--(BUSINESS WIRE)--Fabentech, azienda biofarmaceutica francese specializzata in contromisure mediche contro le minacce biologiche, ha annunciato oggi di aver ricevuto l'autorizzazione alla commercializzazione per Ricimed®, un trattamento contro l'avvelenamento da ricina. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare al testo in lingua...

LYON, Frankreich--(BUSINESS WIRE)--Fabentech, ein französisches biopharmazeutisches Unternehmen, das sich auf medizinische Gegenmaßnahmen gegen biologische Bedrohungen spezialisiert hat, gibt heute bekannt, dass es die Marktzulassung für Ricimed® erhalten hat, ein Medikament zur Behandlung von Rizinvergiftungen. Ricimed®, ein Gegenmittel gegen eine der giftigsten natürlichen Substanzen der Welt Zusätzlich zur unterstützenden Behandlung und in schweren Fällen, die eine sofortige Verabreichung er...

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/13/2026 Issue ¦ GE Capital European Funding - Series 4661 EUR 50,000,000 FRN Due 15 Oct 2032     ISIN Number ¦ XS0322844779 ISIN Reference ¦ 32284477 Issue Nomin EUR ¦ 50000000 Period ¦ 1/15/2026 to 4/15/2026   Payment Date 4/15/2026 Number of Days ¦ 90 Rate ¦ 2.566   Denomination EUR ¦ 50000   ¦ 50000000   ¦       Amount Payable per Denomination ¦ 320.75   ¦ 320750   ¦       Bank of New York    ...

LONDON--(BUSINESS WIRE)--  Oberon AIM VCT Net Asset Value (s) As at the close on the 31ST December 2025 and based on mid market prices, the net asset value of the Oberon AIM VCT was 27.54p per share....

GREAT FALLS, Mont.--(BUSINESS WIRE)--For a second consecutive year, Kovacich Snipes Johnson partners Mark Kovacich and Ben Snipes are the only Montana-based lawyers included in the Lawdragon 500 Leading Lawyers in America legal guide. Mr. Kovacich and Mr. Snipes are both recognized for excellence in plaintiff personal injury/mass torts litigation in the 2026 edition. Dominated by major market attorneys, the list nonetheless takes note of the work done by attorneys nationwide “who inspire us and...

LYON, France--(BUSINESS WIRE)--Fabentech, société biopharmaceutique française spécialisée dans les contre-mesures médicales de lutte contre les menaces biologiques, annonce aujourd'hui avoir obtenu l'autorisation de mise sur le marché de Ricimed®, un traitement contre l'intoxication à la ricine. Ricimed®, un antidote contre l'une des substances naturelles les plus toxiques au monde En complément des soins de soutien, et dans les conditions graves nécessitant une administration immédiate, Ricime...